Medicine Grand Rounds: Dr. Robert Gabbay presents “American Diabetes Association 2022 Standards of Medical Care in Diabetes – New Guidelines”

Robert A. Gabbay, MD, PhD, FACP, is the Chief Scientific and Medical Officer for the American Diabetes Association (ADA), the global authority on diabetes. Dr. Gabbay leads the ADA’s efforts to drive discovery within the world of diabetes research, care and prevention.

With over 35 years of clinical and research experience, and as a practicing endocrinologist, Dr. Gabbay has extensive experience in interventions targeting primary care and quality improvement. His research has been focused on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes.

Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. The reach of his work has been recognized through leadership roles in national and international activities including serving as a visiting professor, keynote speaker and on organizing committees for global meetings of the ADA, International Diabetes Federation, Endocrine Society, and the Diabetes Technology Society. Along with an extensive peer reviewed publication record, he has also appeared in popular press including the New York Times, CNN, Oprah, the Washington Post and NPR.

Previously, Dr. Gabbay served as the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. At Joslin, he oversaw the clinical care for over 25,000 patients, as well as the education and care programs Joslin delivers nationally and internationally.

Dr. Gabbay obtained his B.Sc. Degree at McGill University and his Ph.D. in Biochemistry from the University of Wisconsin where he published on mechanisms of insulin signaling. He received his M.D. from the State University of New York at Brooklyn School of Medicine with a residency in Internal Medicine at New York Hospital-Cornell and a fellowship in Endocrinology, Diabetes and Metabolism at a joint Joslin-Beth Israel Deaconess-Brigham and Women’s Hospital program at Harvard University. Dr. Gabbay was also a visiting scientist at MIT and a Professor of Medicine at Pennsylvania State University College of Medicine.